|
RESEARCH TRIANGLE PARK, N.C. – To help biopharmaceutical andgovernment organizations better understand how medicines are usedand perform in "real world" settings, Quintiles todayannounced recent signings and commitments to multiple sources ofdata that will give it access to de-identified electronic medicalrecords (EMR) data representing 40 million patient lives. When these licensing agreements take effect, Quintiles will havesignificantly expanded the amount of HIPAA-compliant EMR data its researchers can use to help healthcare stakeholdersbetter understand real-world treatments and outcomes, and forclinical trial planning to enhance drug development efficiency. The EMR data are primarily from U.S.-based medical practices andhealth systems; it is anticipated that such data from othercountries will be added in the future. The data reflect arepresentative sample of the healthcare experiences and detailedclinical treatment of patients across all therapeutic categoriesand from a wide variety of U.S. healthcare settings. "Biopharma and governmental organizations need moreclinically rich data to better evaluate the safety, effectivenessand value of healthcare products and services in actual clinicalpractice," said Richard Gliklich, M.D., President, QuintilesOutcome, the real-world and late phase division of Quintiles."These recent agreements, and our plans to add researchexperts who have worked with these data over many years, provideQuintiles with a critical mass of high-quality and clinically richpatient-level data to find answers to research questions morerapidly. "I believe access to these data by experienced researchersalso will promote more efficient clinical trial planning anddesign, patient recruitment, and other clinical developmentservices." Quintiles is in the process of adding a research and analysis teamthat is expert in the use of the new EMR data for both prospectiveand retrospective observational research. These experts willprovide customers insights useful in outcomes research; healtheconomics; epidemiology; medical informatics; quality reporting;and pricing and reimbursement, among other uses. Quintiles" vision is to use data and analytics to provide itscustomers with knowledge-based services and solutions thatdramatically improve efficiency, productivity and quality acrossthe spectrum from clinical development to healthcare delivery. About Quintiles Quintiles is the only fully integrated biopharmaceutical servicescompany offering clinical, commercial, consulting and capitalsolutions worldwide. Our network of more than 25,000 professionalsin 60 countries has an eye on the future while delivering resultstoday with an unwavering commitment to patients, safety and ethics.Quintiles helps biopharmaceutical companies develop andcommercialize products to improve and lengthen patients"lives while demonstrating value to stakeholders. Visit for more information and /news for additional company news. We are high quality suppliers, our products such as Steel Billet Casting Manufacturer , Continuous Casting Machine for oversee buyer. To know more, please visits Continuous Casting Machine.
Related Articles -
Steel Billet Casting Manufacturer, Continuous Casting Machine,
|
